BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22689600)

  • 1. BOOP as a rare complication of gemcitabine therapy.
    Kawsar HI; Spiro TP; Cocco A; Daw HA
    BMJ Case Rep; 2011 Jul; 2011():. PubMed ID: 22689600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bronchiolitis obliterans organizing pneumonia induced by chemotherapy].
    Aguiar Bujanda D; Aguiar Morales J; Bohn Sarmiento U
    Arch Bronconeumol; 2004 Jun; 40(6):290. PubMed ID: 15161598
    [No Abstract]   [Full Text] [Related]  

  • 3. Bronchiolitis obliterans organizing pneumonia simulating progression in bronchioloalveolar carcinoma.
    Cobo Dols M; Gil Calle S; Alés Díaz I; Villar Chamorro E; Alcaide García J; Gutiérrez Calderón V; Benavides Orgaz M
    Clin Transl Oncol; 2006 Feb; 8(2):133-5. PubMed ID: 16632429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Severe interstitial pneumonitis related to Gemcitabine].
    Sabria-Trias J; Bonnaud F; Sioniac M
    Rev Mal Respir; 2002 Oct; 19(5 Pt 1):645-7. PubMed ID: 12473953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gemcitabine-induced pulmonary toxicity during adjuvant therapy in a patient with pancreatic cancer.
    Shaib W; Lansigan F; Cornfeld D; Syrigos K; Saif MW
    JOP; 2008 Nov; 9(6):708-14. PubMed ID: 18981552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The novel and effective nonplatinum, nontaxane combination of gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma: potential for decreased toxicity and combination with biological therapy.
    Herbst RS; Khuri FR; Lu C; Liu DD; Fossella FV; Glisson BS; Pisters KM; Shin DM; Papadimitrakopoulou VA; Kurie JM; Blumenschein G; Kies MS; Zinner R; Jung MS; Lu R; Lee JJ; Munden RF; Hong WK; Lee JS
    Cancer; 2002 Jul; 95(2):340-53. PubMed ID: 12124835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bronchiolitis obliterans-organizing pneumonia: an Italian experience.
    Cazzato S; Zompatori M; Baruzzi G; Schiattone ML; Burzi M; Rossi A; Ratta L; Terzuolo G; Falcone F; Poletti V
    Respir Med; 2000 Jul; 94(7):702-8. PubMed ID: 10926343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical case of the month. Pulmonary toxicity due to gemcitabine for NSCLC with brain metastasis].
    Mommens V; Bosquée L; D'Orio V
    Rev Med Liege; 2003 Mar; 58(3):123-6. PubMed ID: 12723505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Favorable outcome of gemcitabine-induced acute respiratory distress syndrome].
    Bonnichon A; Vedrine L; Aletti M; Le Moulec S; Borne M; Margery J; Bauduceau O; Fayolle M; Ceccaldi B
    Rev Pneumol Clin; 2007 Dec; 63(6):379-83. PubMed ID: 18166944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azacitidine-induced cryptogenic organizing pneumonia: a case report and review of the literature.
    Alnimer Y; Salah S; Abuqayas B; Alrabi K
    J Med Case Rep; 2016 Jan; 10():15. PubMed ID: 26791087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gemcitabine-induced pulmonary toxicity: case report and review of the literature.
    Gupta N; Ahmed I; Steinberg H; Patel D; Nissel-Horowitz S; Mehrotra B
    Am J Clin Oncol; 2002 Feb; 25(1):96-100. PubMed ID: 11823707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of gemcitabine-induced acute interstitial pneumonia with imatinib mesylate: a case report.
    Fenocchio E; Depetris I; Campanella D; Garetto L; Schianca FC; Galizia D; Grignani G; Aglietta M; Leone F
    BMC Cancer; 2016 Oct; 16(1):793. PubMed ID: 27733144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of second-line gemcitabine in sensitive or refractory small cell lung cancer.
    Hoang T; Kim K; Jaslowski A; Koch P; Beatty P; McGovern J; Quisumbing M; Shapiro G; Witte R; Schiller JH
    Lung Cancer; 2003 Oct; 42(1):97-102. PubMed ID: 14512193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gemcitabine, cisplatin, and hyperfractionated accelerated radiotherapy for locally advanced non-small cell lung cancer.
    Zwitter M; Kovac V; Smrdel U; Strojan P
    J Thorac Oncol; 2006 Sep; 1(7):662-6. PubMed ID: 17409933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatal pulmonary toxicity resulting from treatment with gemcitabine.
    Pavlakis N; Bell DR; Millward MJ; Levi JA
    Cancer; 1997 Jul; 80(2):286-91. PubMed ID: 9217042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gemcitabine-induced pulmonary toxicity.
    Chi DC; Brogan F; Turenne I; Zelonis S; Schwartz L; Saif MW
    Anticancer Res; 2012 Sep; 32(9):4147-9. PubMed ID: 22993376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bronchiolitis obliterans with organizing pneumonia in a patient treated with amiodarone].
    Boras Z; Krizanac S; Rakusić N
    Lijec Vjesn; 2003; 125(5-6):131-4. PubMed ID: 14533463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bronchiolitis interstitial pneumonitis: a pathologic study of 31 lung biopsies with features intermediate between bronchiolitis obliterans organizing pneumonia and usual interstitial pneumonitis, with clinical correlation.
    Mark EJ; Ruangchira-urai R
    Ann Diagn Pathol; 2008 Jun; 12(3):171-80. PubMed ID: 18486892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity and toxicity of gemcitabine and gemcitabine + vinorelbine in advanced non-small-cell lung cancer elderly patients: Phase II data from the Multicenter Italian Lung Cancer in the Elderly Study (MILES) randomized trial.
    Gridelli C; Cigolari S; Gallo C; Manzione L; Ianniello GP; Frontini L; Ferraù F; Robbiati SF; Adamo V; Gasparini G; Novello S; Perrone F;
    Lung Cancer; 2001; 31(2-3):277-84. PubMed ID: 11165408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bronchiolitis obliterans organizing pneumonia. Clinical and roentgenological features in 26 cases.
    Oymak FS; Demirbaş HM; Mavili E; Akgun H; Gulmez I; Demir R; Ozesmi M
    Respiration; 2005; 72(3):254-62. PubMed ID: 15942294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.